Effect of Time to Dasatinib Initiation on Outcome of Imatinib-Intolerant Patients with Chronic-Phase Chronic Myelogenous Leukemia (Cp-Cml): Results from a European Observational Study (Forte; Ca180-211)
AuthID
P-005-06R
P-005-06R